TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with Melissa Sevigny (Sev-inn-nee), Science Journalist and Author, “Brave the Wild River: The Untold Story of Two Women Who Mapped the Botany of the Grand Canyon”. Then, Emory University Professor Dr. Cassandra Quave is in search of plants for medical botany. Her book is, “The Plant Hunter: A Scientist’s Quest for Nature’s Next Medicines”

On this week’s Tech Nation, Moira speaks with Melissa Sevigny (Sev-inn-nee), Science Journalist and Author, “Brave the Wild River: The Untold Story of Two Women Who Mapped the Botany of the Grand Canyon”. Then, Emory University Professor Dr. Cassandra Quave is in search of plants for medical botany. Her book is, “The Plant Hunter: A Scientist’s Quest for Nature’s Next Medicines”

On this week’s Tech Nation, Moira speaks with Bloomberg BusinessWeek investigative journalist Kit Chellel (“Shell-lel”) talks about “Dead in the Water … A True Story of Hijacking, Murder, and a Global Maritime Conspiracy.” It makes the movie “Captain Philips” look pretty tame. Then if you thought that all the new vaccines would be mRNA vaccines – you’d be wrong. Dr. Robert Coleman, the Co-Founder and CEO of Codagenix, shows us how to precisely engineer viruses to be effective vaccines. Even better, these can be delivered nasally – there’s no need for a needle.

On this week’s Tech Nation, conjure up images of test tubes, and replace it with tiny wells on index-card-size trays, and robots moving them to and fro. Dr. Chris Gibson, the CEO of Recursion Pharmaceuticals, tells us about their effort to analyze all of human biology, and the drugs in their very own pipeline. Then, who knew Sociology and Criminology were linked? University of Denver professor Jared Del Rosso talks about his book “Denial … How We Hide, Ignore, and Explain Away Problems””, and answers the question – will the election deniers *always* believe the 2020 presidential election was stolen?

On this week’s Tech Nation, Moira speaks with Pulitzer Prize-winning author, Ed Humes. His latest is “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double Murder.” We get an object lesson in the Three Ages of DNA, and while it reads like a fast-paced Cold Case on steroids – it provides details no fiction writer would dare to make up, like the unexpected involvement of the famous true crimes writer, Ann Rule, and a person whose DNA skills are familiar to fans of the PBS documentary series, “Finding your roots with Henry Louis Gates, Jr.”

On this week’s Tech Nation, Moira speaks with Jamie Susskind about his book, “The Digital Republic … On Freedom and Democracy in the 21st Century”. Then, in Biotech, a potential successor to stem cells - fibroblasts? Yes, fibroblasts. Dr. Hamid Khoja, Chief Scientific Officer of FibroBiologics in Houston, describes their fibroblast programs in such diverse conditions as Degenerative Disk Disease, Multiple Sclerosis and Diabetic Foot Ulcers.

On this week’s Tech Nation, Moira speaks with Journalists Dade Hayes & Dawn Chmielewski about “Binge Times: Inside Hollywood’s Furious Billion-Dollar Battle to Take Down Netflix”. From the stock plunge of Netflix to the rise of Bridgerton, it’s a streaming war for our attention. Then in Biotech, could “sticky proteins” lead to Alzheimer’s, Parkinson’s, ALS and more? Dr. Maria Maccecchini, Founder, President and CEO of Annovis Bio, tells us about their approach.

On this week’s Tech Nation, Moira speaks with Bruce Schoenfeld, journalist and author of “Game of Edges …The Analytics Revolution and the Future of Professional Sports.”, about the data revolution in professional sports.

On this week’s Tech Nation, Moira speaks with Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, talks about how they’re engineering mRNA to address Parkinson’s and Alzheimer’s. Then, Dr. Pail Peter Tak, CEO of Candel Therapeutics is using immuno-oncology treatments to go after solid tumors as well as cancers which have metastasized.

Founding Executive Editor at Wired magazine Kevin Kelly is here with “Excellent Advice for Living … Wisdom I Wish I’d Known Earlier.” Then two different efforts from the front lines of fighting cancer. Dr. Paul Lammers from Triumvira Immunologics tells us about their approach, both as a complement to such existing treatments as Keytruda, and as a standalone cancer drug in its own. Then Dr. Philip Kantoff from Convergent Therapeutics tells about their efforts in the most advanced, intractable prostate cancer.